- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avita Medical Ltd (RCEL)
Avita Medical Ltd stock price live, this page displays NASDAQ RCEL stock exchange data. View the RCEL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Avita Medical Ltd real time stock price chart below.
What Is the Avita Medical Ltd Stock Price Today?
The Avita Medical Ltd stock price today is 5.42.
What Is the Stock Symbol for Avita Medical Ltd?
The stock ticker symbol for Avita Medical Ltd is RCEL.
Is RCEL the Same as $RCEL?
$RCEL is a common way to refer to the Avita Medical Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Avita Medical Ltd Trade On?
Avita Medical Ltd is listed and trades on the NASDAQ stock exchange.
Is Avita Medical Ltd a Good Stock to Buy?
Determining whether Avita Medical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Avita Medical Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RCEL quote. (ISIN: US05380C1027)
What Is the Avita Medical Ltd Stock Price Today?
The Avita Medical Ltd stock price today is 5.42.
What Is the Stock Symbol for Avita Medical Ltd?
The stock ticker symbol for Avita Medical Ltd is RCEL.
Is RCEL the Same as $RCEL?
$RCEL is a common way to refer to the Avita Medical Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Avita Medical Ltd Trade On?
Avita Medical Ltd is listed and trades on the NASDAQ stock exchange.
Is Avita Medical Ltd a Good Stock to Buy?
Determining whether Avita Medical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Avita Medical Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RCEL quote. (ISIN: US05380C1027)
5.42
-0.19(-3.30%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.40
5.58
52 wk Range
3.22
10.29
RCEL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.405.58
52 wk Range
3.2210.29
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RCEL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
8.58
Upside
+58.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Avita Medical Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form S-3 Avita Medical Ltd For: 31 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Avita Medical Ltd SWOT Analysis
Global Growth Strategy | Delve into AVITA's international expansion efforts, including recent entry into Australian and New Zealand markets, as the company seeks to diversify revenue streams |
Product Pipeline Powe | Explore AVITA's expanding portfolio, including RECELL GO, PermeaDerm, and Cohealyx, poised to drive market expansion and boost sales in coming fiscal yea |
Financial Crossroads | Despite recent revenue miss, AVITA projects 55-65% YoY growth for FY2025. Analysts maintain cautious optimism with price targets ranging from $11 to $21 |
Regenerative Pionee | AVITA Medical leads in burn treatments and wound care with innovative RECELL system, boasting an 86% gross margin and ambitious growth plans |
Avita Medical Ltd Earnings Call Summary for Q4/2025
- Avita Medical reported Q4 2025 revenue of $17.6 million (0.46% above forecast) with EPS of -$0.38, while full-year revenue reached $71.6 million, an 11% YoY increase.
- Gross margins declined from 85.8% in 2024 to 82.1% in 2025, though operating expenses decreased by 9% ($10.4 million), as the company focused on 200 key burn centers.
- Despite meeting earnings expectations, RCEL stock fell 3.13% in aftermarket trading to $3.84, reflecting broader market caution rather than company performance.
- Management projects 2026 revenue between $80-85 million (12-19% growth), with Interim CEO Cary Vance emphasizing execution and growth across all product lines.
- The company ended Q4 with $18.2 million in cash and marketable securities, while pursuing product innovation and international expansion strategies.
Last Updated: 02/12/2026, 05:18 PM
Read Full TranscriptAvita Medical investor slides for Q4/2025
Last Update: Feb 12, 2026
See full investor slides
Compare RCEL to Peers and Sector
Metrics to compare | RCEL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRCELPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.4x | 12.4x | −0.5x | |
PEG Ratio | −0.13 | −0.04 | 0.00 | |
Price / Book | −10.0x | 2.7x | 2.6x | |
Price / LTM Sales | 2.3x | 4.9x | 3.2x | |
Upside (Analyst Target) | 80.3% | 153.3% | 47.6% | |
Fair Value Upside | Unlock | 26.7% | 6.1% | Unlock |
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.58
(+58.28% Upside)
Earnings
Latest Release
Feb 12, 2026
EPS / Forecast
-0.38 / -0.38
Revenue / Forecast
17.6M / 17.52M
People Also Watch
FAQ
What Is the Avita Medical (RCEL) Stock Price Today?
The Avita Medical stock price today is 5.42 USD.
What Stock Exchange Does Avita Medical Trade On?
Avita Medical is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Avita Medical?
The stock symbol for Avita Medical is "RCEL."
What Is the Avita Medical Market Cap?
As of today, Avita Medical market cap is 166.19M USD.
What Is Avita Medical's Earnings Per Share (TTM)?
The Avita Medical EPS (TTM) is -1.74.
When Is the Next Avita Medical Earnings Date?
Avita Medical will release its next earnings report on May 07, 2026.
From a Technical Analysis Perspective, Is RCEL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Avita Medical Stock Split?
Avita Medical has split 1 times.
How Many Employees Does Avita Medical Have?
Avita Medical has 226 employees.
What is the current trading status of Avita Medical (RCEL)?
As of Apr 15, 2026, Avita Medical (RCEL) is trading at a price of 5.42 USD, with a previous close of 5.60 USD. The stock has fluctuated within a day range of 5.40 USD to 5.58 USD, while its 52-week range spans from 3.22 USD to 10.29 USD.
What Is Avita Medical (RCEL) Price Target According to Analysts?
The average 12-month price target for Avita Medical is 8.58 USD, with a high estimate of 10.11642026 USD and a low estimate of 5.50317834 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +58.28% Upside potential.
What Is the RCEL Premarket Price?
RCEL's last pre-market stock price is 5.47 USD. The pre-market share volume is 3,910.00, and the stock has decreased by -0.13, or -2.32%.
What Is the RCEL After Hours Price?
RCEL's last after hours stock price is 5.74 USD, the stock has decreased by 0.14, or 2.50%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.